<?xml version="1.0" encoding="UTF-8"?>
<p id="para0020">Currently, tocilizumab is being investigated in an FDA-approved randomized, double-blind, placebo-controlled phase III clinical trial to evaluate its safety and efficacy when used with standard of care in hospitalized adult patients with severe COVID-19 and in a phase II study in Italy approved by the Italian Agency of Pharmaceutics.</p>
